Nachrichten zu Ardelyx

Startseite > Aktien > Ardelyx > Nachrichten

Ardelyx Aktie

Aktie

ISIN: US0396971071 WKN: A116X0 SYM: ARDX Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

6,3100

USD

+1,45 %

+0,0900 USD

Letzter Kurs 14.09.24 Nasdaq

Geldkurs

13.09.24

6,3000

USD

1.300 STK

Briefkurs

13.09.24

6,3100

USD

27.600 STK

Ardelyx Aktie kaufen

Kauf

Verkauf

Neueste Nachrichten

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx 14.09.24 · newsfile · Ardelyx
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX 14.09.24 · newsfile · Ardelyx
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX 11.09.24 · newsfile · Ardelyx
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx 10.09.24 · newsfile · Ardelyx
ROSEN, A TOP RANKED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX 09.09.24 · newsfile · Ardelyx
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX 08.09.24 · newsfile · Ardelyx
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx 07.09.24 · newsfile · Ardelyx
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX 07.09.24 · newsfile · Ardelyx
ROSEN, A TOP RANKED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX 06.09.24 · newsfile · Ardelyx
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference 05.09.24 · globenewswire · Ardelyx
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX 05.09.24 · newsfile · Ardelyx
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX 04.09.24 · newsfile · Ardelyx

1
2
3
4
5
…
7

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel ... 128 Leser
ROSEN, A TOP RANKED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important ... 124 Leser
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx 108 Leser
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before ... 108 Leser
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx 104 Leser

Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference 584 Leser
ARDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ardelyx, Inc. Investors Can ... 460 Leser
ROSEN, A LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important ... 268 Leser
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before ... 264 Leser
ROSEN, A TOP RANKED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important ... 232 Leser
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx 228 Leser
ROSEN, A LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important ... 228 Leser
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before ... 224 Leser
ARDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ardelyx, Inc. Investors Can Join the Class Action ... 224 Leser
ARDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ardelyx, Inc. Investors Can ... 208 Leser

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update 1816 Leser
To Preserve Patient Access to XPHOZAH, Ardelyx Chooses Not to File for TDAPA 1452 Leser
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update 764 Leser
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference 584 Leser
Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic Priorities 516 Leser
ARDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ardelyx, Inc. Investors Can ... 460 Leser
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH (tenapanor) 424 Leser
Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to ... 424 Leser
Ardelyx to Present Data Updates for XPHOZAH (tenapanor) for Hyperphosphatemia at Kidney Week 2023 ... 340 Leser
Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across ... 336 Leser